Shenzhen Dongyangguang Industry

HEC Group is a large-scale Chinese conglomerate with a dominant presence in the pharmaceutical industry through its subsidiaries, Sunshine Lake Pharma and YiChang HEC ChangJiang Pharmaceutical. The company operates a fully integrated business model covering drug discovery, clinical development, and high-volume manufacturing of both innovative drugs and high-end generics. HEC Group is a global leader in the production of oseltamivir (marketed as Kewei), which commands a significant share of the Chinese anti-influenza market. Beyond infectious diseases, the company maintains a robust pipeline focused on metabolic disorders, oncology, and cardiovascular health, supported by R&D centers that meet international regulatory standards.